Regional effects of phosphodiesterase-5 (pde5) inhibitors on gastric smooth muscle contractility in vitro.

被引：0
|
作者：
Martin, JS
Thomas, RM
Ryan, JP
Parkman, HP
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A548 / A548
页数：1
相关论文
共 50 条
  • [41] TESTOSTERONE REGULATES SMOOTH MUSCLE CONTRACTILE PATHWAYS IN THE RAT PROSTATE: EMPHASIS ON PHOSPHODIESTERASE V (PDE5) SIGNALING
    Zhang, Xinhua
    Zang, Ning
    Wei, Yu
    Yin, Jing
    Teng, Ruobing
    Seftel, Allen
    DiSanto, Michael
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E634 - E634
  • [42] Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury
    Priyanka Kalyani
    Sara M. Lippa
    J. Kent Werner
    Franck Amyot
    Carol B. Moore
    Kimbra Kenney
    Ramon Diaz-Arrastia
    [J]. Neurotherapeutics, 2023, 20 (6) : 1629 - 1640
  • [43] Differential effects of selective PDE5 inhibitors in rat cerebral arteries in vitro and in vivo
    Kruuse, C.
    Gupta, S.
    Nilsson, E.
    Kruse, L. S.
    Olesen, J.
    Edvinsson, L.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S123 - S123
  • [44] Erectile dysfunction and the role of phosphodiesterase-5 (PDE-5) inhibitors in schizophrenia. A brief review
    Dimopoulos, N. P.
    Mitsonis, C. I.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S111 - S112
  • [45] Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects
    Foresta, C.
    Caretta, N.
    Zuccarello, D.
    Poletti, A.
    Biagioli, A.
    Caretti, L.
    Galan, A.
    [J]. EYE, 2008, 22 (01) : 144 - 149
  • [46] Phosphodiesterase-5 (PDE-5) Inhibitors as Emergent Environmental Contaminants: Advanced Remediation and Analytical Methods
    Bianco, Giuliana
    Foti, Luca
    Pascale, Raffaella
    Lelario, Filomena
    Coviello, Donatella
    Brienza, Monica
    Bufo, Sabino Aurelio
    Scrano, Laura
    [J]. WATER, 2021, 13 (20)
  • [47] Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury
    Kalyani, Priyanka
    Lippa, Sara M.
    Werner, J. Kent
    Amyot, Franck
    Moore, Carol B.
    Kenney, Kimbra
    Diaz-Arrastia, Ramon
    [J]. NEUROTHERAPEUTICS, 2023, 20 (06) : 1629 - 1640
  • [48] Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects
    C Foresta
    N Caretta
    D Zuccarello
    A Poletti
    A Biagioli
    L Caretti
    A Galan
    [J]. Eye, 2008, 22 : 144 - 149
  • [49] AOAC SMPR 2014.011: Determination of phosphodiesterase type 5 (PDE5) inhibitors in dietary ingredients and supplements
    Mastovska, Katerina
    Arora, Saurabh
    Betz, Joseph
    Bzhelyansky, Anton
    Cain, Teresa
    Chlenov, Anatoly
    Edwards, John
    Giancaspro, Gabriel
    Hildreth, Jana
    Ingle, Prashant
    Kennedy, David
    Koch, Todd
    Krynitsky, Alexander
    Lock, Stephen
    Neal-Kababick, James
    Nickum, Elisa
    Phillips, Melissa
    Rimmer, Catherine
    Royce, Steve
    Schaneberg, Brian
    Shimelis, Olga
    Sullivan, Darryl
    Travis, John
    Vaclavik, Lukas
    Yu, Kate
    Zielinski, Garrett
    Zweigenbaum, Jerry
    Coates, Scott
    [J]. Journal of AOAC International, 2015, 98 (04) : 1064 - 1067
  • [50] Evidence for pharmacological contamination of herbal erectile function products with type 5 phosphodiesterase (PDE5) inhibitors
    Fleshner, NE
    Harvey, M
    Adomat, H
    Wood, C
    Hersey, K
    Guns, E
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 314 - 314
12345